TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,036 | -22.7% | 409,517 | 0.0% | 0.16% | -56.8% |
| Q2 2023 | $389,492 | +1.2% | 409,517 | 0.0% | 0.37% | +2.2% |
| Q1 2023 | $384,946 | -5.1% | 409,517 | 0.0% | 0.36% | +13.7% |
| Q4 2022 | $405,422 | -7.6% | 409,517 | 0.0% | 0.32% | -35.5% |
| Q3 2022 | $439,000 | -12.5% | 409,517 | 0.0% | 0.49% | -22.0% |
| Q2 2022 | $502,000 | +15.7% | 409,517 | 0.0% | 0.63% | +53.4% |
| Q1 2022 | $434,000 | +768.0% | 409,517 | +1067.8% | 0.41% | +920.0% |
| Q4 2021 | $50,000 | – | 35,068 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |